Low-Thrombogenicity Mechanical Heart Valves
نویسندگان
چکیده
منابع مشابه
Anticoagulation for Mechanical Heart Valves
Although mechanical heart valves (MHV) are more durable than tissue valves, they are more thrombogenic. Consequently, patients with MHV require long-term anticoagulation with vitamin K antagonists, such as warfarin. Although effective, warfarin has well-known limitations, including multiple drug and food interactions, and the challenges of coagulation monitoring and maintaining the internationa...
متن کاملElliptic st. jude bileaflet mechanical heart valves
St. Jude Medical (SJM) bileaflet mechanical valves were approved by the Food and Drug Administration in 1977. The SJM valve design consists of two semicircular leaflets which pivot on hinges. Compared to other mechanical heart valve prostheses such as ball and cage and tilting disk prosthetic valves, it provides good central flow, the leaflets open completely, and the pressure drop across the v...
متن کاملHeartbeat: Warfarin therapy for mechanical heart valves.
Although many patients requiring long term anti-thrombotic therapy now can be treated with direct oral anticoagulants (DOACs), vitamin K antagonists, such as warfarin, remain the only treatment option in patients with mechanical heart valves (MHVs). In the future, we can expect that fewer patients will receive (MHVs), given that surgical repair often is possible in patients with mitral valve di...
متن کاملMechanical heart valves: 50 years of evolution.
The past 50 years have witnessed remarkable progress in the development of safe, hemodynamically favorable mechanical heart valves. Starr-Edwards aortic and mitral ball valves introduced in the mid-1960s, continue to be used successfully worldwide. More than 100,000 Omniscience and Omnicarbon tilting-disc valves have been implanted since 1978 with essentially no mechanical failure; similar resu...
متن کاملAnticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin.
The management of pregnant women with mechanical heart valves is challenging. Recently, based on small numbers of patients and poor-quality data, correspondence from Aventis Pharmaceuticals Inc has described treatment "failures" and concerns about teratogenicity with the use of the low-molecular-weight heparin (LMWH) enoxaparin. The company issued a "Warning" that enoxaparin should not be used ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2018
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2018.07.065